Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Sunshine Biopharma (SBFM) Times Interest Earned (2016 - 2024)

Sunshine Biopharma (SBFM) has disclosed Times Interest Earned for 11 consecutive years, with $50.13 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Times Interest Earned rose 227.13% year-over-year to $50.13, compared with a TTM value of $159.27 through Sep 2025, up 355.32%, and an annual FY2024 reading of -$662.43, down 1800.74% over the prior year.
  • Times Interest Earned was $50.13 for Q4 2024 at Sunshine Biopharma, up from -$5176.6 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $50.13 in Q4 2024 and bottomed at -$858990.0 in Q3 2022.
  • Average Times Interest Earned over 5 years is -$48088.2, with a median of -$22.95 recorded in 2021.
  • The sharpest move saw Times Interest Earned crashed 8109137.82% in 2022, then skyrocketed 227.13% in 2024.
  • Year by year, Times Interest Earned stood at -$3.26 in 2020, then crashed by 134.44% to -$7.63 in 2021, then crashed by 11429.02% to -$880.12 in 2022, then soared by 95.52% to -$39.43 in 2023, then surged by 227.13% to $50.13 in 2024.
  • Business Quant data shows Times Interest Earned for SBFM at $50.13 in Q4 2024, -$5176.6 in Q2 2024, and -$27.46 in Q1 2024.